Skip to main content
. 2017 Sep 19;12(9):e0184777. doi: 10.1371/journal.pone.0184777

Fig 5.

Fig 5

Initial response (A) and initial cure (B) rates with Sbv intralesional therapy in New World leishmaniasis studies.